RENSCHLER MARKUS MD - Insider Non-Derivative Transactions at Cyteir Therapeutics, Inc. (CYT) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Mar 4, 2024, RENSCHLER MARKUS MD's relationship to Cyteir Therapeutics, Inc. (CYT) is Director,Officer (President and CEO), and currently has 1,103,661 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other CYT insiders.
Data Source: SEC.
RENSCHLER MARKUS MD - Insider Non-Derivative Transactions of CYT Common Stock
RENSCHLER MARKUS MD - Insider Non-Derivative Transactions at CYT
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Mar 5, 2024 | M -- (Common Stock) | 6304 | 1.69 | 1103661 |
| Mar 1, 2024 | M -- (Common Stock) | 12607 | 1.69 | 1094820 |
| Mar 1, 2024 | M -- (Common Stock) | 2537 | 1.2 | 1097357 |
| Nov 21, 2023 | M -- (Common Stock) | 56737 | 1.69 | 1045473 |
| Nov 21, 2023 | M -- (Common Stock) | 27900 | 1.2 | 1073373 |
| Nov 21, 2023 | M -- (Common Stock) | 6304 | 1.69 | 1079677 |
| Nov 21, 2023 | M -- (Common Stock) | 2536 | 1.2 | 1082213 |
| Jan 14, 2023 | Acquisition -- (Common Stock) | 5000 | 1.49 | 983736 |